Trelstar
NDC Package 52544-092-76
Package Information
Trelstar is triptorelin is used to treat advanced prostate cancer in men. Marketed by Actavis Pharma, Inc., this product is identified by NDC 52544-092 and is authorized under FDA application NDA022437.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 52544 - Actavis Pharma, Inc.
- 52544-092 - Trelstar
- 52544-092-76 - 1 KIT in 1 CARTON * 2 mL in 1 VIAL, SINGLE-DOSE (52544-156-02) * 2 mL in 1 SYRINGE
- 52544-092 - Trelstar
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 52544-092-76 identifies a specific commercial package of 1 kit in 1 carton * 2 ml in 1 vial, single-dose (52544-156-02) * 2 ml in 1 syringe of Trelstar, labeled by Actavis Pharma, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Actavis Pharma, Inc. on March 11, 2010. The current certification is valid through October 31, 2018.
What are the primary indications for this medication?
Triptorelin is used to treat advanced prostate cancer in men. It is not a cure. Most types of prostate cancer need the male hormone testosterone to grow and spread. Triptorelin works by reducing the amount of testosterone that the body makes. This effect helps slow or stop the growth of cancer cells and helps relieve symptoms such as painful/difficult urination. This medication is similar to a natural substance made by the body (luteinizing hormone releasing hormone-LHRH). Talk to your doctor about the risks and benefits of treatment.
How is this Actavis Pharma, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 52544009276. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.